Long-term Results of Adjuvant Imatinib Mesylate in Localized, High-Risk, Primary Gastrointestinal Stromal Tumor: ACOSOG Z9000 (Alliance) Intergroup Phase 2 Trial
暂无分享,去创建一个
C. Antonescu | M. McCarter | K. Owzar | G. Demetri | J. Norton | R. Maki | R. DeMatteo | C. Corless | M. von Mehren | K. Ballman | P. Pisters | M. Brennan | V. Kolesnikova | Peter W. T. Pisters